Sikander Ailawadhi, MD, discusses how the studies presented at ASH 2024 highlight significant unmet needs in hematologic cancer management, emphasizing the potential for these findings to influence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback